Inflammatory Bowel Syndrome With Diarrhea

Disease State Hub

FDA Alerts

IBS

FDA Roundup: New Options for IBS and COPD

05/29/2015

The FDA has approved 2 new drugs for the treatment of irritable bowel syndrome and a new option for chronic obstructive pulmonary disease.

05/29/2015

Research Summaries

guidelines

AGA Updates IBS-D Guidelines

07/15/2022

The American Gastroenterological Association has updated its guidelines on the management of irritable bowel syndrome with diarrhea.

07/15/2022

Exocrine Pancreatic Insufficiency

Undiagnosed EPI May Be Prevalent in Individuals With IBS-D

06/29/2022

Researchers examined the presence of undiagnosed severe exocrine pancreatic insufficiency in individuals with irritable bowel syndrome plus diarrhea, as well as the associated symptoms and the impact of...

06/29/2022

diarrhea

AGA Develops Guideline for the Laboratory Evaluation of Functional Diarrhea, IBS-D

09/24/2019

The American Gastroenterological Association’s guideline applies to the evaluation of patients who are immunocompetent and who have had “watery” diarrhea for at least 4 weeks.

09/24/2019

diarrhea

Fecal Primary Bile Acids: An Alternative in Chronic Diarrhea Diagnosis?

04/19/2019

Researchers compared results from available diagnostic tests for bile acid diarrhea with increased fecal weight and rapid colonic transit over different periods among patients with irritable bowel syndrome...

04/19/2019

Diet

Gene Limits Effectiveness of Low-Carb Diet on IBS-D

01/23/2019

While a diet low in FODMAPs has been proven to be effective in reducing gastrointestinal symptoms among some patients with IBS-D, the effect had not yet been studied in relation to a specific genotype. ...

01/23/2019

October 2024

Current Issue

October 2024

Volume 64

Issue 9